RIV Competitors

Delisted . USA . 
Stock . RIV Capital
RIV Capital competes with Grown Rogue, AYR Strategies, and Verano Holdings; as well as few others. The company classifies itself under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. Analyzing RIV Capital competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of RIV Capital to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of RIV Capital competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.000.000.00
Details
Intrinsic
Valuation
LowRealHigh
0.000.000.00
Details

RIV Capital Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between RIV Capital and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of RIV and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of RIV Capital does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
VRNOF
+ 0.92
AYRWF
VRNOF
+ 0.72
GRUSF
AYRWF
+ 0.69
GRUSF
GRUSF
+ 0.45
FFNTF
GRUSF
+ 0.39
MPXOF
FFNTF
+ 0.38
MPXOF
  
High negative correlations   
DBCCF
- 0.27
FFNTF
GRUSF
- 0.24
DBCCF
VRNOF
- 0.0
TRSSF
TRSSF
- 0.0
AYRWF
VRNOF
- 0.0
ACRDF
TRSSF
- 0.0
ACRDF

Risk-Adjusted Indicators

There is a big difference between RIV Pink Sheet performing well and RIV Capital Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze RIV Capital's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
MPXOF  52.55  21.42  0.00 (6.21) 0.00 
 0.00 
 0.00 
(81.82)
 990.00 
FFNTF  15.06  0.87  0.08 (0.39) 16.56 
(17.38)
 34.55 
(30.43)
 112.87 
STHZF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
DBCCF  4.91  0.36  0.06  1.18  6.33 
(5.08)
 10.15 
(9.09)
 32.81 
GRUSF  1.97 (0.32) 0.00 (0.76) 0.00 
 0.00 
 4.62 
(4.92)
 14.59 
ACRDF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
AYRWF  5.90 (1.36) 0.00 (1.38) 0.00 
 0.00 
 9.52 
(13.33)
 41.94 
TRSSF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
VRNOF  4.70 (0.73) 0.00 (0.58) 0.00 
 0.00 
 8.04 
(11.81)
 37.26 
All Fundamental Data

RIV Capital Competitive Analysis

The better you understand RIV Capital competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, RIV Capital's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across RIV Capital's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
MPXOF FFNTF STHZF DBCCF GRUSF AYRWF VRNOF MEDIF CWBHF TGIFF
 0.00 
 0.0001 
MPX
 18.12 
 0.02 
4Front
 0.00 
 0.01 
StateHouse
 9.09 
 0.05 
Decibel
 1.96 
 0.52 
Grown
 5.88 
 0.16 
AYR
 1.56 
 0.65 
Verano
 13.21 
 0.06 
Medipharm
 1.12 
 0.09 
Charlottes
 111.76 
 0.01 
1933
Market Volatility
(90 Days Market Risk)
Out of control
Out of control
Somewhat reliable
Out of control
Abnormally volatile
Out of control
Out of control
Out of control
Out of control
Out of control
Market Performance
(90 Days Performance)
Good
OK
Very Weak
Weak
Very Weak
Very Weak
Very Weak
OK
Very Weak
Good
Odds of Financial Distress
(Probability Of Bankruptcy)
Average
Average
Quite High
Quite High
Low
High
Above Average
Low
Above Average
Average
Current Valuation
(Equity Enterprise Value)
Over Valued
Fairly Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Cautious Hold
Current Ratio
0.47
0.74
0.3
1.36
1.61
2.19
0.49
5.23
4.63
1.36
Net Asset
50.67 M
255.54 M
153.82 M
125.93 M
14.21 M
1.86 B
2.55 B
92.36 M
171.51 M
29.01 M
Profit Margin
N/A
-0.32
-0.73
-0.0098
0.0557
-0.13
-0.0204
-2.07
-1.78
-1.14
EBITDA
(16.01 M)
(4.02 M)
(846.46 K)
9.45 M
(193.65 K)
87.69 M
212.47 M
(38.55 M)
(38.03 M)
(13.83 M)
Operating Margin
-2.56
-0.15
-0.31
0.066
0.2
-0.14
0.14
-1.61
-0.48
-0.37
Current Valuation
18.4 M
433.05 M
162.29 M
59.18 M
21.02 M
656.77 M
1.53 B
3.05 M
113.32 M
19.37 M
Price To Book
0.19
5.13
0.35
0.71
3.47
0.13
0.74
0.36
0.99
0.94
Beta
0.82
1.81
1.8
1.29
0.51
2.25
N/A
1.15
2.18
1.13
Number Of Employees
5
464
6
7
11
2.5 K
3.89 K
190
257
71
Shares Outstanding
144.32 M
640.39 M
252.59 M
404 M
170.63 M
59.02 M
324.32 M
280.51 M
151.63 M
454.2 M
Cash Flow From Operations
(8.13 M)
5.78 M
(15.28 M)
(17.15 M)
(238.46 K)
(27.78 M)
181.2 M
(13.21 M)
(29.56 M)
(5.09 M)
Total Debt
7.47 M
64.62 M
11.85 M
24.06 M
1.37 M
371.15 M
276.15 M
1.44 M
21.71 M
18.09 M
Return On Equity
-1.64
-0.74
-0.9
-0.0133
0.26
-0.0642
-0.0103
-0.57
-0.81
-1.16
Z Score
N/A
1.2
0.6
1.2
8.4
N/A
1.8
6.6
1.8
N/A
Return On Asset
-0.22
-0.0398
-0.0666
0.0212
0.15
-0.022
0.0291
-0.24
-0.11
-0.0974
Book Value Per Share
0.048
0.077
0.32
0.12
0.043
14.17
4.58
0.22
0.75
0.018
Total Asset
50.67 M
255.54 M
153.82 M
125.93 M
14.21 M
1.86 B
2.55 B
92.36 M
171.51 M
29.01 M
Debt To Equity
2.56
3.72
0.96
1.06
0.53
0.64
0.31
0.021
0.19
1.6
Target Price
N/A
2.37
N/A
N/A
0.54
7.5
42.1
N/A
1.13
N/A
Shares Owned By Institutions
N/A
4.59
0.1
0.28
16.71
7.34
3.0
7.05
13.91
0.21
Market Capitalization
540.18 K
151.58 M
20.23 M
53.21 M
20.48 M
86.74 M
992.41 M
16.26 M
77.33 M
8.5 M
Price To Earning
N/A
N/A
N/A
N/A
N/A
N/A
9.56
N/A
73.7
N/A
Price To Earnings To Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Price To Sales
0.0772
1.83
0.29
0.42
1.01
0.25
1.3
0.69
1.22
0.44
Net Income
(26.63 M)
(38.31 M)
(26.16 M)
1.74 M
(1.01 M)
(16.95 M)
(14.68 M)
(54.8 M)
(137.72 M)
(17.81 M)
Earnings Per Share
-0.15
-0.055
N/A
N/A
-0.013
-0.12
0.06
-0.14
-0.94
-0.007
Shares Owned By Insiders
14.09
34.18
9.4
2.46
22.76
1.84
18.86
3.92
1.07
7.53
Revenue
7.21 M
104.57 M
60.3 M
52.45 M
9.38 M
357.61 M
737.85 M
21.71 M
96.09 M
12.54 M
Cash And Equivalents
2.36 M
6.03 M
10.92 M
3.13 M
1.53 M
116.74 M
92.83 M
21.99 M
14.82 M
966.05 K
Cash Per Share
0.02
0.01
0.04
0.01
0.01
1.7
0.28
0.08
0.1
N/A
Gross Profit
3.98 M
49.4 M
22.34 M
28.17 M
6.1 M
181.96 M
415.55 M
(13.42 M)
47.53 M
(109.93 K)
Day Typical Price
1.0E-4
0.0156
0.015
0.05
0.51
0.17
0.66
0.06
0.09
0.0061
Accumulation Distribution
N/A
0.13
N/A
N/A
0.0769
9988.89
2063.16
N/A
N/A
11805.56
Market Facilitation Index
N/A
0.0022
N/A
N/A
0.04
N/A
0.0
N/A
N/A
N/A
Daily Balance Of Power
0.0
1.136364
0.0
(9,223,372,036,855)
0.25
(0.50)
0.3333
9.2 T
9.2 T
1.117647
Period Momentum Indicator
N/A
0.0025
N/A
(0.01)
0.01
(0.01)
0.01
0.007
0.001
0.0038
Rate Of Daily Change
1.0
1.18
1.0
0.91
1.02
0.94
1.02
1.13
1.01
2.12
Day Median Price
1.0E-4
0.0152
0.015
0.05
0.5
0.17
0.67
0.06
0.09
0.0055
Price Action Indicator
N/A
0.0024
N/A
(0)
0.025
(0.01)
(0.01)
0.0035
5.0E-4
0.0036
Coefficient Of Variation
622.95
1450.02
N/A
2045.79
(712.13)
(524.33)
(675.52)
1131.05
(3,489)
934.08
Mean Deviation
52.55
15.06
N/A
4.91
1.97
5.9
4.7
4.44
4.71
18.8
Jensen Alpha
21.42
0.8658
N/A
0.357
(0.32)
(1.36)
(0.73)
0.2415
(0.12)
3.57
Total Risk Alpha
44.94
4.71
N/A
1.45
0.068
(0.19)
0.1224
1.4
0.9072
8.23
Sortino Ratio
N/A
0.084
N/A
0.0634
N/A
N/A
N/A
0.1239
N/A
0.1526
Downside Variance
N/A
320.2
N/A
52.82
N/A
N/A
N/A
24.72
N/A
477.71
Standard Deviation
136.6
19.87
N/A
6.73
2.78
7.89
6.46
5.47
6.56
29.91
Kurtosis
28.94
1.42
N/A
1.81
1.62
0.7812
3.79
(0.48)
(0.37)
8.58
Potential Upside
N/A
34.55
N/A
10.15
4.62
9.52
8.04
11.11
10.0
56.76
Treynor Ratio
(6.21)
(0.39)
N/A
1.18
(0.76)
(1.38)
(0.58)
(0.29)
(0.34)
1.2
Maximum Drawdown
990.0
112.87
N/A
32.81
14.59
41.94
37.26
21.0
25.46
191.3
Variance
18660.53
394.74
N/A
45.23
7.7
62.31
41.79
29.95
43.01
894.86
Market Risk Adjusted Performance
(6.20)
(0.38)
N/A
1.19
(0.75)
(1.37)
(0.57)
(0.28)
(0.33)
1.21
Risk Adjusted Performance
0.1455
0.0678
N/A
0.05
(0.11)
(0.15)
(0.12)
0.0831
(0.02)
0.1001
Skewness
5.15
0.5556
N/A
(0.11)
0.3411
0.2246
0.8833
0.3844
(0.07)
2.2
Semi Deviation
N/A
16.56
N/A
6.33
N/A
N/A
N/A
4.41
N/A
17.87
Information Ratio
0.1615
0.0756
N/A
0.0685
(0.09)
(0.17)
(0.13)
0.1126
(0.01)
0.1115
Value At Risk
(81.82)
(30.43)
N/A
(9.09)
(4.92)
(13.33)
(11.81)
(7.84)
(9.09)
(38.46)
Expected Short fall
N/A
(17.38)
N/A
(5.08)
N/A
N/A
N/A
(5.54)
N/A
(27.01)
Downside Deviation
N/A
17.89
N/A
7.27
N/A
N/A
N/A
4.97
N/A
21.86
Semi Variance
N/A
274.39
N/A
40.06
N/A
N/A
N/A
19.42
N/A
319.28

RIV Capital Competition Performance Charts

Five steps to successful analysis of RIV Capital Competition

RIV Capital's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by RIV Capital in relation to its competition. RIV Capital's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of RIV Capital in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact RIV Capital's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to RIV Capital, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your RIV Capital position

In addition to having RIV Capital in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Financials ETFs Thematic Idea Now

Financials ETFs
Financials ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Financials ETFs theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Financials ETFs Theme or any other thematic opportunities.
View All  Next Launch
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Consideration for investing in RIV Pink Sheet

If you are still planning to invest in RIV Capital check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the RIV Capital's history and understand the potential risks before investing.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY